As of 2026-04-09T17:03:23Z (UTC), CMS's April Medicare Advantage package is easy to flatten into one bullish number: 2.48%, or more than $13 billion in additional payments to MA plans for calendar year 2027.[1][2] That is the headline CMS published on April 6, 2026, and it is materially higher than the 0.09% average change shown in the January 26, 2026 Advance Notice.[2][4] If you stop there, the file looks like a simple retreat from a tougher payment update.

That reading misses the more useful policy signal. CMS did not abandon payment-accuracy concerns. It chose to delay a larger risk-model recalibration for one year, keep using the 2024 MA risk adjustment model for CY 2027, and still move ahead with narrower controls on what diagnoses count for payment.[1][2][3] Inference from the CMS materials: this is a stability-first reset, not a surrender on coding discipline.

Image context: the cover photo shows the HHS headquarters entrance in Washington because this story turns on federal program design rather than a hospital scene or an insurer earnings call. The live question is how CMS is sequencing payment accuracy, bid stability, and operational change inside Medicare Advantage.[7]

What changed between the January proposal and the April final package

The January Advance Notice pointed toward a much harsher 2027 payment year. CMS projected an average 0.09% increase after showing a -3.32% impact from risk-model revision and normalization plus a -1.53% hit from diagnosis-source changes.[4] The proposal also contemplated a refreshed MA risk adjustment model using newer diagnosis and expenditure data, along with exclusion of diagnoses from audio-only encounters and from unlinked chart review records.[4]

The April Rate Announcement changed the balance of that package.[2][3] CMS now says the average payment impact is 2.48%, with the risk-model revision and normalization line reduced to -1.12%.[2] The central reason is explicit in the fact sheet and press release: CMS is not implementing the proposed 2027 MA risk adjustment model and will instead continue using the 2024 model for CY 2027 while it evaluates feedback for future updates.[1][2]

That is why the 2.48% number should not be read as a generic payment giveaway. The increase is partly the mechanical result of CMS stepping back from a more aggressive methodological update that plans had already spent months fighting.[2][4][6]

Why this is a pause-on-recalibration story

CMS framed the decision as a sequencing choice. The press release says the agency considered the impact that the 2024 MA risk adjustment model already had between CY 2024 and CY 2026 and therefore will continue using that model for CY 2027.[1] The Rate Announcement PDF makes the same point in more administrative language: the agency wants targeted risk-adjustment policies that promote more accurate payments, but it is not moving to the next model generation yet.[3]

That matters because the payment debate in Medicare Advantage is no longer just about annual benchmark growth. It is about whether CMS can narrow persistent overpayment and coding-intensity concerns without destabilizing plan bids, benefits, or participation. KFF's April 8 readout captures the broader backdrop: payments to MA plans remain elevated relative to similar beneficiaries in traditional Medicare, and CMS's decision to back off a key payment update lifts 2027 plan revenue relative to the January proposal.[6]

So the practical interpretation is narrower than either side's public messaging. This is not a clean pro-industry victory, because CMS left several accuracy-focused policies in place. It is also not a full payment-tightening cycle, because the agency deferred the biggest model refresh. The result is a midpoint: recalibration later, narrower coding clamps now.[1][2][4][6]

The coding clamp is still real even after the larger model update was postponed

The easiest mistake in reading the April package is to assume that keeping the 2024 risk model means nothing changed on coding inputs. That is not what CMS finalized.

First, CMS is excluding diagnoses from unlinked chart review records from risk-score calculation, while carving out an exception for beneficiaries who switch from one MA organization to another.[1][2] The fact sheet says the diagnosis-source change still carries an average -1.53% impact, and it notes that excluding unlinked chart reviews without the switcher exception would have been an even larger drag of -1.78%.[2]

Second, CMS is finalizing exclusion of diagnoses from audio-only services identified with modifiers, even though the average payment impact from that step is 0% on the fact-sheet table.[2][3] Zero average impact does not mean zero compliance significance. It means CMS is continuing to narrow what counts as risk-adjustment evidence even in a year when it paused the broader model rewrite.

Third, the separate April 2, 2026 MA and Part D final rule focused mainly on Star Ratings changes and streamlined enrollment processes rather than reopening the core payment-model fight.[5] Put differently, CMS split the April package into two tracks: a rule file about program operations and quality measurement, and a rate file about how hard to press payment accuracy in 2027.[2][5]

Decision impact by horizon

Next 24 hours: plans, investors, and consultants can mark the immediate conclusion that 2027 revenue pressure is lighter than the January proposal implied.[2][4][6] The bid-year headline is relief.

Next 7 days: actuarial and bid teams still need to work through the coding-input rules rather than treating April 6 as a pure payment uplift. The continued exclusion of audio-only diagnoses and most unlinked chart reviews means documentation strategy, chart-review economics, and member-switch handling still matter.[1][2][3]

Next 30 days: the bigger question is whether CMS uses the one-year pause to build a more durable future model update or whether political resistance keeps pushing recalibration outward. The agency explicitly says it will evaluate feedback as it considers future risk-adjustment changes.[1][3]

Scenario map

Base case: CY 2027 becomes a transition year in which plans enjoy higher benchmark support than feared, but still adjust operations for narrower coding inputs. Trigger: no major further CMS reversal before bid and implementation workflows lock in.[1][2][3]

Upside for plans: CMS treats the 2027 pause as the start of a slower, more incremental risk-model path, which would reduce the chance of another sharp payment-methodology shock in the near term. Trigger: later CMS guidance emphasizes gradualism over a quick return to a full model refresh.[1][3]

Downside for plans: the 2027 relief only defers the harder fight, and CMS comes back with a broader recalibration after gathering comments while the chart-review and audio-only restrictions are already in force. Trigger: future notices signal a revived model update on top of the coding-input limits already finalized.[1][3][4]

Action checklist

  1. Treat the 2.48% figure as a reset from the January proposal, not as proof that payment-accuracy pressure has disappeared.[2][4]
  2. Rework bid and compliance assumptions around the policies CMS actually kept: the 2024 MA risk model, exclusion of audio-only diagnoses, and exclusion of most unlinked chart review records.[1][2][3]
  3. Separate the April files operationally. The April 2 final rule is about program rules and Star Ratings; the April 6 Rate Announcement is where the bigger payment-methodology choice was made.[2][5]
  4. Watch future CMS notices for signs that the agency intends to revive a broader risk-model update after the 2027 pause. That is the main invalidation condition for anyone reading April as a durable settlement rather than a sequencing decision.[1][3]

Bottom line

CMS's April 2026 Medicare Advantage package did not turn into a simple "plans win" story. The agency backed away from a larger 2027 risk-model update and that is why the payment headline improved so sharply from 0.09% to 2.48%.[2][4] But CMS also kept meaningful coding-discipline changes in place and used the accompanying rule file to tighten other parts of the MA and Part D operating framework.[1][2][5] The most useful reading, therefore, is not that payment accuracy went away. It is that CMS chose to pursue it in a narrower 2027 form while postponing the bigger recalibration fight.[1][3][6]

Sources

  1. Centers for Medicare & Medicaid Services, "CMS Finalizes 2027 Medicare Advantage and Part D Payment Policies that Strengthen Accountability and Long-Term Sustainability" (Apr. 6, 2026).
  2. Centers for Medicare & Medicaid Services, "2027 Medicare Advantage and Part D Rate Announcement" (Apr. 6, 2026).
  3. Centers for Medicare & Medicaid Services, Announcement of Calendar Year (CY) 2027 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (PDF, Apr. 6, 2026).
  4. Centers for Medicare & Medicaid Services, "2027 Medicare Advantage and Part D Advance Notice" (Jan. 26, 2026).
  5. Centers for Medicare & Medicaid Services, "Contract Year 2027 Medicare Advantage and Part D Final Rule" (Apr. 2, 2026).
  6. KFF, "Medicare Advantage Insurers Will See Higher Payments as CMS Backs Off a Key Payment Update" (Apr. 8, 2026).
  7. Wikimedia Commons, "File: Dept Health and Human Services HQ entrance Washington DC 2025-02-07 13-59-35 1.jpg" (image source).